Literature DB >> 31305159

Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling.

Qiang Zhou1, Tongzhou Hu2, Yuan Xu3.   

Abstract

Development of cisplatin (DDP)-resistance is a major challenge that largely limits the efficacy of chemotherapy for osteosarcoma. LncRNA Taurine up-regulated gene 1 (TUG1) is a recently identified oncogenic lncRNA that has been involved in chemo-resistance of various cancers. In this study, over-expression of TUG1 was found in two osteosarcoma cell lines resistant to DDP (Saos-2/DDP, MG-63/DDP). Knockdown of TUG1 inhibited the DDP-resistance and promoted the cytotoxicity and apoptosis induced by DDP in Saos-2/DDP and MG-63/DDP cells. TUG1 knockdown also markedly inhibited the expression level of MET and p-Akt. In conclusion, knockdown of TUG1 suppressed cell growth and increased apoptotic rate under DDP treatment possibly via regulating MET/Akt signalling pathway.

Entities:  

Keywords:  Akt; DDP-resistance; MET; Osteosarcoma; TUG1; apoptosis

Mesh:

Substances:

Year:  2019        PMID: 31305159     DOI: 10.1080/1061186X.2019.1644651

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  7 in total

1.  Retracted Article: Macrophage-derived exosomes mediate osteosarcoma cell behavior by activating AKT signaling.

Authors:  Bin Yan; Qingbai Liu; Gang Liu; Xiaoyi Huang; Guangming Zhu; Luoluo Gao; Yaozeng Xu
Journal:  RSC Adv       Date:  2020-01-30       Impact factor: 4.036

2.  CircEIF4G2 Promotes Tumorigenesis and Progression of Osteosarcoma by Sponging miR-218.

Authors:  Erhu Lin; Shuai Liu; Wei Xiang; Hongbo Zhang; Chaofan Xie
Journal:  Biomed Res Int       Date:  2020-05-23       Impact factor: 3.411

3.  Interactions Between lncRNA TUG1 and miR-9-5p Modulate the Resistance of Breast Cancer Cells to Doxorubicin by Regulating eIF5A2.

Authors:  Shuqian Wang; Mengjing Cheng; Xiaoxiao Zheng; Li Zheng; Hao Liu; Jianju Lu; Yu Liu; Wei Chen
Journal:  Onco Targets Ther       Date:  2020-12-23       Impact factor: 4.147

Review 4.  Role of long noncoding RNA taurine-upregulated gene 1 in cancers.

Authors:  Miao Da; Jing Zhuang; Yani Zhou; Quan Qi; Shuwen Han
Journal:  Mol Med       Date:  2021-05-26       Impact factor: 6.354

Review 5.  Origin and Therapies of Osteosarcoma.

Authors:  Brice Moukengue; Morgane Lallier; Louise Marchandet; Marc Baud'huin; Franck Verrecchia; Benjamin Ory; Francois Lamoureux
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

Review 6.  MicroRNAs: Harbingers and shapers of periodontal inflammation.

Authors:  Xianghong Luan; Xiaofeng Zhou; Pooria Fallah; Mirali Pandya; Huling Lyu; Deborah Foyle; Dan Burch; Thomas G H Diekwisch
Journal:  Semin Cell Dev Biol       Date:  2021-06-10       Impact factor: 7.499

Review 7.  Small and Long Non-coding RNAs as Functional Regulators of Bone Homeostasis, Acting Alone or Cooperatively.

Authors:  Mateusz Sikora; Krzysztof Marycz; Agnieszka Smieszek
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-15       Impact factor: 8.886

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.